{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T10:07:09Z","timestamp":1780826829311,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijantimicag.2013.07.017","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T03:02:40Z","timestamp":1378436560000},"page":"395-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009\u20132012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and \u03b2-lactam resistance"],"prefix":"10.1016","volume":"42","author":[{"given":"Meng-Rui","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yi","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2012.08.015","article-title":"Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in cancer patients","volume":"65","author":"Garcia-Vidal","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0010","doi-asserted-by":"crossref","first-page":"e51452","DOI":"10.1371\/journal.pone.0051452","article-title":"Pneumococcal pneumonia and the risk of stroke: a population-based follow-up study","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0015","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in the molecular epidemiology of Streptococcus pneumoniae causing meningitis following the introduction of pneumococcal conjugate vaccination in England and Wales","volume":"51","author":"Pichon","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MD.0b013e3181f2b824","article-title":"The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century","volume":"89","author":"Rueda","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0025","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","article-title":"Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31824de9f6","article-title":"The worldwide impact of the seven-valent pneumococcal conjugate vaccine","volume":"31","author":"Fitzwater","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0035","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2009.06.091","article-title":"National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential","volume":"27","author":"Hsieh","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10096-010-0873-7","article-title":"Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan","volume":"29","author":"Liao","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2011.09.025","article-title":"Diagnosis of pneumococcal empyema using immunochromatographic test on pleural fluid and serotype distribution in Korean children","volume":"72","author":"Lee","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/INF.0b013e31828637b1","article-title":"Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age","volume":"32","author":"Lin","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0060","doi-asserted-by":"crossref","unstructured":"Lai CY, Huang LM, Lee PY, Lu CY, Shao PL, Chang LY. Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease. J Microbiol Immunol Infect 2012;pii: S1684-1182(12)00172-7. http:\/\/dx.doi.org\/10.1016\/j.jmii.2012.08.011 [Epub ahead of print].","DOI":"10.1016\/j.jmii.2012.08.011"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/archdischild-2012-301790","article-title":"Emergence of pneumococcal 19A empyema in UK children","volume":"97","author":"Thomas","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/INF.0b013e31827e8594","article-title":"Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011","volume":"32","author":"Picazo","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0075","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/archinte.167.15.1635","article-title":"Defining the population-based burden of nosocomial pneumococcal bacteremia","volume":"167","author":"Lyytikainen","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10096-011-1210-5","article-title":"Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000\u20132010","volume":"30","author":"Lee","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhin.2010.11.014","article-title":"Healthcare-associated bacteraemia caused by Leuconostoc species at a university hospital in Taiwan between 1995 and 2008","volume":"78","author":"Lee","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0090","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 9th ed. Document M07-A9. Wayne, PA: CLSI; 2012."},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0095","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Document M100-S23. Wayne, PA: CLSI; 2013."},{"issue":"Suppl 6","key":"10.1016\/j.ijantimicag.2013.07.017_bib0100","doi-asserted-by":"crossref","first-page":"G32","DOI":"10.1016\/j.vaccine.2012.07.030","article-title":"Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA)","volume":"30","author":"Shibl","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0105","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0110","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/650496","article-title":"Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era","volume":"201","author":"Gertz","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0115","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.vaccine.2012.12.066","article-title":"13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label trial","volume":"31","author":"Silfverdal","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0120","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1139\/w2012-073","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010","volume":"58","author":"Demczuk","year":"2012","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0125","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid1811.120454","article-title":"Streptococcus pneumoniae serotype 15A in psychiatric unit, Rhode Island, USA, 2010\u20132011","volume":"18","author":"Fleming-Dutra","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/INF.0b013e31825384ae","article-title":"Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy","volume":"31","author":"Esposito","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0135","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/656579","article-title":"Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples","volume":"51","author":"Resti","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/INF.0b013e3182788fdd","article-title":"Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine","volume":"32","author":"Sharma","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0145","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijantimicag.2010.04.001","article-title":"Comparison of clinical features, antimicrobial susceptibility, serotype distribution and outcomes of patients with hospital- and community-associated invasive pneumococcal disease","volume":"36","author":"Lin","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0155","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10096-011-1251-9","article-title":"Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine","volume":"30","author":"Grall","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0160","doi-asserted-by":"crossref","unstructured":"Miyaji EN, Oliveira ML, Carvalho E, Ho PL. Serotype-independent pneumococcal vaccines. Cell Mol Life Sci 2012 Dec 27 [Epub ahead of print].","DOI":"10.1007\/s00018-012-1234-8"},{"key":"10.1016\/j.ijantimicag.2013.07.017_bib0165","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/AAC.47.10.3155-3160.2003","article-title":"Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T09:16:07Z","timestamp":1563873367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913002896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924857913002896"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009\u20132012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and \u03b2-lactam resistance","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}